Aurobindo Pharma Shares Jump Over 6% After $900-Million US Acquisition
Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900...
No comments:
Post a Comment